Benzinga's Top #PreMarket Gainers

shares rose 11.45 percent to $19.86 in pre-market trading after the company reported upbeat results for the first quarter and lifted its sales forecast fiscal 2016.

shares climbed 7.64 percent to $63.00 in pre-market trading after the company reported stronger-than-expected results for the first quarter.

shares climbed 6.61 percent to $71.00 in pre-market trading after the company announced data from ISIS-SMN Rx Phase 2 study in infants with spinal muscular atrophy. The company reported increases in median event free survive and muscle function scores.

gained 6.03 percent to $18.45 in pre-market trading after the company reported better-than-expected earnings for the first quarter.

shares surged 3.60 percent to $21.00 in pre-market trading. Integrated Silicon Solution and Uphill reported an agreement for purchase of ISSI at $21 per share.